Federal Tipoffs Involving Delaware Newsletter for Sunday October 08, 2023 ( 2 items ) |
Justice Dept.: Genomic Health Agrees to Pay $32.5 Million to Resolve Allegations Relating to the Submission of False Claims for Genetic Cancer Screening Tests
WASHINGTON, Oct. 3 -- The U.S. Department of Justice issued the following news release:
Genomic Health, Inc. (GHI), a Delaware corporation headquartered in Redwood City, California, has agreed to pay $32.5 million to resolve allegations that it violated the False Claims Act by engaging in a nationwide scheme to improperly bill Medicare for certain laboratory tests used to diagnose and treat cancer patients. GHI is a wholly owned subsidiary of Exact Sciences Corporation, which acquired GHI in No
more
Justice Dept.: U.S. Settles Kickback Allegations With BioTek ReMEDys Inc., Chaitanya Gadde and Dr. David Tabby
WASHINGTON, Oct. 3 -- The U.S. Department of Justice issued the following news release:
BioTek reMEDys Inc. (BioTek), located in New Castle, Delaware, and its chief executive officer, Chaitanya Gadde, have agreed collectively to pay $20 million based on their ability to pay to resolve allegations that they violated the False Claims Act by paying kickbacks to patients and physicians to protect its revenue stream.
When a Medicare beneficiary obtains a prescription drug covered by Medicare, the b
more
|
Sign up to Receive this newsletter every day via email.